ERIC BJERKHOLT Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ERIC BJERKHOLT.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ERIC BJERKHOLT. ERIC BJERKHOLT is Director in STEMCELLS INC ($STEM) and Director in CERUS CORP ($CERS) and EVP, CFO & Corp. Secretary in SUNESIS PHARMACEUTICALS INC ($SNSS) and Chief Financial Officer in CHINOOK THERAPEUTICS, INC. ($ADRO) and Director in GRAYBUG VISION, INC. ($GRAY) and Director in Corium International, Inc. ($CORI) and Chief Financial Officer in Aimmune Therapeutics, Inc. ($AIMT).
Latest Insider Trading Transactions of ERIC BJERKHOLT
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AIMT, CERS, ADRO, CORI, GRAY, MBOT, SNSS
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 12 2021 | ADRO | CHINOOK THERAPEUTI ... | BJERKHOLT ERIC | Chief Financial Off ... | Option Exercise | A | 0.00 | 7,304 | 0 | 7,304 | |
| Feb 12 2021 | ADRO | CHINOOK THERAPEUTI ... | BJERKHOLT ERIC | Chief Financial Off ... | Option Exercise | A | 15.14 | 21,501 | 325,525 | 21,501 | |
| Dec 18 2020 | ADRO | CHINOOK THERAPEUTI ... | BJERKHOLT ERIC | Chief Financial Off ... | Option Exercise | A | 0.00 | 49,243 | 0 | 49,243 | |
| Dec 18 2020 | ADRO | CHINOOK THERAPEUTI ... | BJERKHOLT ERIC | Chief Financial Off ... | Option Exercise | A | 13.98 | 144,787 | 2,024,122 | 144,787 | |
| Oct 14 2020 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Option Exercise | D | 23.81 | 56,250 | 1,339,313 | 0 | |
| Oct 14 2020 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Option Exercise | D | 23.72 | 78,750 | 1,867,950 | 0 | |
| Oct 14 2020 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Option Exercise | D | 34.07 | 56,250 | 1,916,438 | 0 | |
| Oct 14 2020 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Option Exercise | D | 19.44 | 264,800 | 5,147,712 | 0 | |
| Oct 14 2020 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Sell | D | 34.50 | 23,905 | 824,723 | 0 | 23.9 K to 0 (-100.00 %) |
| Oct 14 2020 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Sell | U | 34.50 | 27,805 | 959,273 | 0 | 27.8 K to 0 (-100.00 %) |
| Oct 05 2020 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Option Exercise | M | 19.44 | 5,200 | 101,088 | 264,800 | |
| Oct 05 2020 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Buy | M | 19.44 | 5,200 | 101,088 | 49,841 | 44.6 K to 49.8 K (+11.65 %) |
| Oct 05 2020 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Option Exercise | M | 19.44 | 5,200 | 101,088 | 264,800 | |
| Oct 05 2020 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Buy | M | 19.44 | 5,200 | 101,088 | 49,841 | 44.6 K to 49.8 K (+11.65 %) |
| Sep 28 2020 | GRAY | GRAYBUG VISION, IN ... | BJERKHOLT ERIC | Director | Option Exercise | A | 16.00 | 25,000 | 400,000 | 25,000 | |
| Sep 16 2020 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Payment of Exercise | F | 34.25 | 840 | 28,770 | 44,547 | 45.4 K to 44.5 K (-1.85 %) |
| Jun 05 2020 | CERS | CERUS CORP | BJERKHOLT ERIC | Director | Option Exercise | A | 0.00 | 13,228 | 0 | 13,228 | |
| Jun 05 2020 | CERS | CERUS CORP | BJERKHOLT ERIC | Director | Option Exercise | A | 6.37 | 28,177 | 179,487 | 28,177 | |
| May 12 2020 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Grant | A | 0.00 | 2,420 | 0 | 45,387 | 43 K to 45.4 K (+5.63 %) |
| Mar 12 2020 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Buy | P | 15.10 | 1,000 | 15,100 | 42,967 | 42 K to 43 K (+2.38 %) |
| Mar 10 2020 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Buy | P | 18.97 | 1,000 | 18,970 | 41,967 | 41 K to 42 K (+2.44 %) |
| Mar 04 2020 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Payment of Exercise | F | 23.81 | 1,982 | 47,191 | 40,967 | 42.9 K to 41 K (-4.61 %) |
| Mar 03 2020 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Option Exercise | A | 23.81 | 56,250 | 1,339,313 | 56,250 | |
| Mar 03 2020 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Grant | A | 0.00 | 9,375 | 0 | 42,949 | 33.6 K to 42.9 K (+27.92 %) |
| Feb 03 2020 | CERS | CERUS CORP | BJERKHOLT ERIC | Director | Buy | P | 4.15 | 20,000 | 83,000 | 24,282 | 4.3 K to 24.3 K (+467.07 %) |
| Oct 04 2019 | CERS | CERUS CORP | BJERKHOLT ERIC | Director | Option Exercise | M | 0.00 | 4,282 | 0 | 8,562 | |
| Oct 04 2019 | CERS | CERUS CORP | BJERKHOLT ERIC | Director | Buy | M | 0.00 | 4,282 | 0 | 4,282 | 0 to 4.3 K |
| Sep 20 2019 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Buy | P | 22.57 | 1,550 | 34,977 | 33,574 | 32 K to 33.6 K (+4.84 %) |
| Sep 20 2019 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Buy | P | 22.57 | 1,550 | 34,977 | 33,574 | 32 K to 33.6 K (+4.84 %) |
| Jun 07 2019 | CERS | CERUS CORP | BJERKHOLT ERIC | Director | Option Exercise | A | 0.00 | 11,184 | 0 | 11,184 | |
| Jun 07 2019 | CERS | CERUS CORP | BJERKHOLT ERIC | Director | Option Exercise | A | 4.80 | 23,703 | 113,774 | 23,703 | |
| Feb 26 2019 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Option Exercise | A | 23.72 | 78,750 | 1,867,950 | 78,750 | |
| Feb 26 2019 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Grant | A | 0.00 | 13,125 | 0 | 32,857 | 19.7 K to 32.9 K (+66.52 %) |
| Nov 28 2018 | CORI | Corium Internation ... | BJERKHOLT ERIC | Director | Option Exercise | D | 11.59 | 15,000 | 173,850 | 0 | |
| Nov 28 2018 | CORI | Corium Internation ... | BJERKHOLT ERIC | Director | Option Exercise | D | 4.59 | 15,000 | 68,850 | 0 | |
| Nov 28 2018 | CORI | Corium Internation ... | BJERKHOLT ERIC | Director | Option Exercise | D | 7.19 | 12,000 | 86,280 | 0 | |
| Nov 28 2018 | CORI | Corium Internation ... | BJERKHOLT ERIC | Director | Option Exercise | D | 7.97 | 20,000 | 159,400 | 0 | |
| Nov 28 2018 | CORI | Corium Internation ... | BJERKHOLT ERIC | Director | Sell | D | 12.50 | 12,000 | 150,000 | 0 | 12 K to 0 (-100.00 %) |
| Nov 28 2018 | CORI | Corium Internation ... | BJERKHOLT ERIC | Director | Sell | D | 12.50 | 12,500 | 156,250 | 0 | 12.5 K to 0 (-100.00 %) |
| Oct 09 2018 | CERS | CERUS CORP | BJERKHOLT ERIC | Director | Option Exercise | A | 0.00 | 12,844 | 0 | 12,844 | |
| Oct 09 2018 | CERS | CERUS CORP | BJERKHOLT ERIC | Director | Option Exercise | A | 6.49 | 24,013 | 155,844 | 24,013 | |
| Jun 14 2018 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Buy | P | 30.41 | 1,600 | 48,663 | 19,485 | 17.9 K to 19.5 K (+8.95 %) |
| Mar 06 2018 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Option Exercise | A | 34.07 | 56,250 | 1,916,438 | 56,250 | |
| Mar 06 2018 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Grant | A | 0.00 | 9,375 | 0 | 17,500 | 8.1 K to 17.5 K (+115.38 %) |
| Feb 26 2018 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Buy | P | 32.00 | 3,125 | 100,000 | 8,125 | 5 K to 8.1 K (+62.50 %) |
| Dec 05 2017 | CORI | Corium Internation ... | BJERKHOLT ERIC | Director | Option Exercise | A | 11.59 | 15,000 | 173,850 | 15,000 | |
| May 01 2017 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Option Exercise | A | 19.44 | 270,000 | 5,248,800 | 270,000 | |
| Dec 27 2016 | CORI | Corium Internation ... | BJERKHOLT ERIC | Director | Option Exercise | A | 4.59 | 15,000 | 68,850 | 15,000 | |
| Dec 02 2016 | SNSS | SUNESIS PHARMACEUT ... | BJERKHOLT ERIC | EVP, CFO & Corp. Se ... | Option Exercise | A | 4.03 | 95,000 | 382,850 | 95,000 | |
| May 20 2016 | CORI | Corium Internation ... | BJERKHOLT ERIC | Director | Buy | P | 3.70 | 6,341 | 23,453 | 12,000 | 5.7 K to 12 K (+112.05 %) |
| May 20 2016 | CORI | Corium Internation ... | BJERKHOLT ERIC | Director | Buy | P | 3.71 | 7,790 | 28,879 | 12,500 | 4.7 K to 12.5 K (+165.39 %) |
| May 20 2016 | CORI | Corium Internation ... | BJERKHOLT ERIC | Director | Buy | P | 3.57 | 5,659 | 20,179 | 5,659 | 0 to 5.7 K |
| May 20 2016 | CORI | Corium Internation ... | BJERKHOLT ERIC | Director | Buy | P | 3.54 | 4,710 | 16,688 | 4,710 | 0 to 4.7 K |
| Mar 02 2016 | SNSS | SUNESIS PHARMACEUT ... | BJERKHOLT ERIC | EVP, CFO & Corp. Se ... | Payment of Exercise | F | 0.75 | 34,991 | 26,243 | 100,922 | 135.9 K to 100.9 K (-25.75 %) |
| Mar 02 2016 | SNSS | SUNESIS PHARMACEUT ... | BJERKHOLT ERIC | EVP, CFO & Corp. Se ... | Grant | A | 0.00 | 80,000 | 0 | 135,913 | 55.9 K to 135.9 K (+143.08 %) |
| Jan 05 2016 | STEM | STEMCELLS INC | BJERKHOLT ERIC | Director | Grant | A | 0.00 | 146,342 | 0 | 273,759 | 127.4 K to 273.8 K (+114.85 %) |
| Dec 22 2015 | CORI | Corium Internation ... | BJERKHOLT ERIC | Director | Option Exercise | A | 7.19 | 12,000 | 86,280 | 12,000 | |
| Dec 02 2015 | SNSS | SUNESIS PHARMACEUT ... | BJERKHOLT ERIC | EVP, CFO & Corp. Se ... | Option Exercise | A | 1.03 | 270,000 | 278,100 | 270,000 | |
| Jul 28 2015 | SNSS | SUNESIS PHARMACEUT ... | BJERKHOLT ERIC | EVP, CFO & Corp. Se ... | Option Exercise | X | 1.32 | 5,551 | 7,327 | 0 | |
| Jul 28 2015 | SNSS | SUNESIS PHARMACEUT ... | BJERKHOLT ERIC | EVP, CFO & Corp. Se ... | Option Exercise | X | 1.32 | 11,105 | 14,659 | 0 | |
| Jul 28 2015 | SNSS | SUNESIS PHARMACEUT ... | BJERKHOLT ERIC | EVP, CFO & Corp. Se ... | Sell | S | 3.46 | 2,119 | 7,329 | 83,827 | 85.9 K to 83.8 K (-2.47 %) |
| Jul 28 2015 | SNSS | SUNESIS PHARMACEUT ... | BJERKHOLT ERIC | EVP, CFO & Corp. Se ... | Buy | X | 1.32 | 5,551 | 7,327 | 85,946 | 80.4 K to 85.9 K (+6.90 %) |
| Jul 28 2015 | SNSS | SUNESIS PHARMACEUT ... | BJERKHOLT ERIC | EVP, CFO & Corp. Se ... | Sell | S | 3.46 | 4,239 | 14,661 | 80,395 | 84.6 K to 80.4 K (-5.01 %) |
| Jul 28 2015 | SNSS | SUNESIS PHARMACEUT ... | BJERKHOLT ERIC | EVP, CFO & Corp. Se ... | Buy | X | 1.32 | 11,105 | 14,659 | 84,634 | 73.5 K to 84.6 K (+15.10 %) |
| Apr 16 2015 | CORI | Corium Internation ... | BJERKHOLT ERIC | Director | Option Exercise | A | 7.97 | 20,000 | 159,400 | 20,000 | |
| Mar 02 2015 | SNSS | SUNESIS PHARMACEUT ... | BJERKHOLT ERIC | EVP, CFO & Corp. Se ... | Payment of Exercise | F | 2.22 | 7,723 | 17,145 | 49,913 | 57.6 K to 49.9 K (-13.40 %) |
| Mar 02 2015 | SNSS | SUNESIS PHARMACEUT ... | BJERKHOLT ERIC | EVP, CFO & Corp. Se ... | Grant | A | 0.00 | 17,642 | 0 | 57,636 | 40 K to 57.6 K (+44.11 %) |
| Mar 02 2011 | STEM | STEMCELLS INC | BJERKHOLT ERIC | Director | Grant | A | 0.00 | 10,000 | 0 | 20,000 | 10 K to 20 K (+100.00 %) |
| Mar 03 2010 | STEM | STEMCELLS INC | BJERKHOLT ERIC | Director | Grant | A | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
| Mar 03 2009 | STEM | STEMCELLS INC | BJERKHOLT ERIC | Director | Option Exercise | A | 1.56 | 10,000 | 15,600 | 10,000 | |
| Mar 04 2008 | STEM | STEMCELLS INC | BJERKHOLT ERIC | Director | Option Exercise | A | 1.51 | 10,000 | 15,100 | 10,000 | |
| Mar 05 2007 | STEM | STEMCELLS INC | BJERKHOLT ERIC | Director | Option Exercise | A | 2.56 | 10,000 | 25,600 | 10,000 | |
| Mar 01 2006 | STEM | STEMCELLS INC | BJERKHOLT ERIC | Director | Option Exercise | A | 3.64 | 10,000 | 36,400 | 10,000 | |
| Mar 01 2005 | STEM | STEMCELLS INC | BJERKHOLT ERIC | Director | Option Exercise | A | 4.33 | 10,000 | 43,300 | 10,000 |
Page: 1